ライブラリ登録: Guest
Critical Reviews™ in Eukaryotic Gene Expression

年間 6 号発行

ISSN 印刷: 1045-4403

ISSN オンライン: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Review of Anti-Bacterial Activities of Curcumin against Pseudomonas aeruginosa

巻 29, 発行 5, 2019, pp. 377-385
DOI: 10.1615/CritRevEukaryotGeneExpr.2019029088
Get accessGet access

要約

The prevention and pharmacotherapy of infectious diseases are of great importance. Among others, infections caused by Pseudomonas aeruginosa have a high mortality rate. This bacterium is the third most common cause of nosocomial infections, and characteristics such as multiple virulence factors, ability to survive, environmental spread, and resistance to antibiotics have made it a potential pathogen, especially for people with compromised immune systems. Considering bacterial resistance to current medications, high cost, and side effects, the need to provide new and effective therapies is highlighted. Curcumin is a dietary polyphenolic compound that has a wide range of therapeutic properties, including antibacterial effects. It has been the subject of increasing research exploring its potential utility in infectious diseases. In this review, the antibacterial effects of curcumin against Pseudomonas aeruginosa are discussed.

参考
  1. Jagetia GC, Aggarwal BB. "Spicing up" of the immune system by curcumin. J Clin Immunol. 2007;27(1):19-35.

  2. Rahimi HR, Kazemi Oskuee R. Curcumin from traditional Iranian medicine to molecular medicine. Razavi Int J Med. 2014;2(2):e19982.

  3. Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: a review of pharma-cokinetic, experimental and clinical studies. Biomed Pharmacother. 2017;85:102-12.

  4. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Alt Comp Med. 2003;9(1):161-8.

  5. Khurana A, Ho C-T. High performance liquid chro-matographic analysis of curcuminoids and their photo-oxidative decomposition compounds in Curcuma longa L. J Liquid Chromatography. 1988;11(11):2295-304.

  6. Zorofchian Moghadamtousi S, Abdul Kadir H, Hassan-darvish P, Tajik H, Abubakar S, Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Res Int. 2014;186864.

  7. Momtazi AA, Shahabipour F, Khatibi S, Johnston TP, Pirro M, Sahebkar A. Curcumin as a microRNA regulator in cancer: a review. Rev Physiol Biochem Pharmacol. 2016;171:1-38.

  8. Karimian MS, Pirro M, Majeed M, Sahebkar A. Curcumin as a natural regulator of monocyte chemoattractant protein-1. Cytokine Growth Factor Rev. 2017;33:55-63.

  9. Panahi Y, Kianpour P, Mohtashami R, Jafari R, Simental-Mendia LE, Sahebkar A. Curcumin lowers serum lipids and uric acid in subjects with nonalcoholic fatty liver disease: a randomized controlled trial. J Cardiovasc Pharmacol. 2016;68(3):223-9.

  10. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann New YorkAcad Sci. 2005;1056(1):206-17.

  11. Vogel A, Pelletier J. Examen chimique de la racine de curcuma. J Pharm. 1815;1:289-300.

  12. Vogel A. Memoire sur la curcumine. J de Pharm et Chim. 1842;2:20-7.

  13. Lampe V, Milobedzka J. Studien uber curcumin. Berichte der Deutschen Chemischen Gesellschaft. 1913;46(2):2235-40.

  14. Srinivasan K. A chromatographic study of the curcuminoids in Curcuma longa L. J Pharm Pharmacol. 1953;5(1):448-57.

  15. Tennesen HH, Karlsen J. Studies on curcumin and curcuminoids. Zeitschrift fur Lebensmitteluntersuchung und-Forschung A. 1985;180(5):402-4.

  16. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci. 2006;78(18):2081-7.

  17. Hatcher H, Planalp R, Cho J, Torti F, Torti S. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631-52.

  18. Rahimi HR, Jaafari MR, Mohammadpour AH, Abnous K, Ghayour Mobarhan M, Ramezanzadeh E, Mousavi F, Kazemi Oskuee R. Curcumin: reintroduced therapeutic agent from traditional medicine for alcoholic liver disease. Asia Pacific J Med Toxicol. 2015;4(1):25-30.

  19. Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Thomas P, Dannenberg AJ. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kB-dependent genes. Am J Physiolo-Gastrointestinal Liver Physiol. 2003;284(2):G321-7.

  20. Rahimi HR, Mohammadpour AH, Dastani M, Jaafari MR, Abnous K, Mobarhan MG, Oskuee RK. The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial. Avicenna J Phytomed. 2016;6(5):567.

  21. Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res. 2013;27(3):374-9.

  22. Hosseini S, Chamani J, Rahimi H, Azmoodeh N, Ghasemi F, Abadi PH. An in vitro study on curcumin delivery by nano-micelles for esophageal squamous cell carcinoma (KYSE-30). Rep Biochem Mol Biol. 2018;6(2):137.

  23. Singh S. From exotic spice to modern drug? Cell. 2007;130(5):765-8.

  24. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M. Antimicrobial resistance is a major threat to public health. BMJ (Clin Res Ed). 1998;317(7159):609-10.

  25. Rudrappa T, Bais HP. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J Agricultural Food Chem. 2008;56(6): 1955-62.

  26. Niamsa N, Sittiwet C. Antimicrobial activity of Curcuma longa aqueous extract. J Pharmacol Toxicol. 2009;4(4):173-7.

  27. Neelofar K, Shreaz S, Rimple B, Muralidhar S, Nikhat M, Khan LA. Curcumin as a promising anticandidal of clinical interest. Can J Microbiol. 2011;57(3):204-10.

  28. Lawhavinit O-a, Kongkathip N, Kongkathip B. Antimicrobial activity of curcuminoids from Curcuma longa L. on pathogenic bacteria of shrimp and chicken. Kasetsart J-Natural Sci. 2010;44(3):364-71.

  29. Hosny I, El Kholy W, Murad H, El Dairouty R. Antimicrobial activity of curcumin upon pathogenic microorganisms during manufacture and storage of a novel style cheese "Karishcum." J Am Sci. 2011;7(5):611-8.

  30. De R, Kundu P, Swarnakar S, Ramamurthy T, Chowdhury A, Nair GB, Mukhopadhyay AK. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob Agents Chemother. 2009;53(4):1592-7.

  31. Tajbakhsh S, Mohammadi K, Deilami I, Zandi K, Fouladvand M, Ramedani E, Asayesh G. Antibacterial activity of indium curcumin and indium diacetylcurcumin. African J Biotechnol. 2008;7(21).

  32. Odds FC. Synergy, antagonism, and what the chequer-board puts between them. J Antimicrob Chemother. 2003;52(1):1.

  33. Tyagi P, Singh M, Kumari H, Kumari A, Mukhopadhyay K. Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS One. 2015;10(3):e0121313.

  34. Mirnejad R, Jahromi M, Ali M, Al-Musawi S, Pirestani M, Fasihi Ramandi M, Ahmadi K, Rajayi H, Mohammad Hassan Z, Kamali M. Curcumin-loaded chitosan tripoly-phosphate nanoparticles as a safe, natural and effective antibiotic inhibits the infection of Staphylococcus aureus and Pseudomonas aeruginosa in vivo. Iranian J Biotechnol. 2014;12(3):1-8.

  35. Mun S-H, Joung D-K, Kim Y-S, Kang O-H, Kim S-B, Seo Y-S, Kim Y-C, Lee D-S, Shin D-W, Kweon K-T. Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus. Phytomedicine. 2013;20(8-9):714-8.

  36. Hatamie S, Nouri M, Karandikar S, Kulkarni A, Dhole S, Phase D, Kale S. Complexes of cobalt nanoparticles and polyfunctional curcumin as antimicrobial agents. Mater Sci Eng: C. 2012;32(2):92-7.

  37. Varaprasad K, Mohan YM, Vimala K, Mohana Raju K. Synthesis and characterization of hydrogel-silver nanoparticle-curcumin composites for wound dressing and antibacterial application. J Appl Polymer Sci. 2011;121(2):784-96.

  38. Hancock REW, Decad GM, Nikaido H. Identification of the protein producing transmembrane diffusion pores in the outer membrane of Pseudomonas aeruginosa PA01. Biochim Biophys Acta-Biomembranes. 1979;554(2):323-31.

  39. Hancock RE, Nikaido H. Outer membranes of Gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol. 1978;136(1): 381-90.

  40. Sykes RB, Morris A. Resistance of Pseudomonas Aeruginosa to Antimicrobial Drugs. In: Ellis GP, West GB, editors. Progress in medicinal chemistry. vol. 12. New York: Elsevier; 1975. p. 333-93.

  41. Yoshimura F, Nikaido H. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J Bacteriol. 1982;152(2):636-42.

  42. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002;34(5):634-40.

  43. Aeschlimann JR. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other Gram-negative bacteria. Pharmacother: J Human Pharmacol Drug Ther. 2012;23(7):916-24.

  44. Miller MB, Bassler BL. Quorum sensing in bacteria. Ann Rev Microbiol. 2001;55:165-99.

  45. Vert M, Doi Y, Hellwich K-H, Hess M, Hodge P, Kubisa P, Rinaudo M, Schue F. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012). Pure Appl Chem. 2012. 2012;84:377-410.

  46. Aghamollaei H, Azizi Baijini K, Moosazadeh Mogaddam M. Rapid detection of Pseudomonas aeruginosa by PCR method using specific primers of quorum sensing lasI gene. Armaghane Danesh. 2013;18(9):723-35.

  47. Negi N, Prakash P, Gupta ML, Mohapatra TM. Possible role of curcumin as an efflux pump inhibitor in multi drug resistant clinical isolates of Pseudomonas aeruginosa. J Clin Diagn Res. 2014;8(10):DC04.

  48. Miller MB, Bassler BL. Quorum sensing in bacteria. Ann Rev Microbiol. 2001;55(1):165-99.

  49. Zhu H, Bandara R, Conibear TC, Thuruthyil SJ, Rice SA, Kjelleberg S, Givskov M, Willcox MD. Pseudomonas aeruginosa with lasI quorum-sensing deficiency during corneal infection. Invest Ophthalmol Vis Sci. 2004;45(6):1897-903.

  50. Sharma G, Rao S, Bansal A, Dang S, Gupta S, Gabrani R. Pseudomonas aeruginosa biofilm: potential therapeutic targets. Biologicals. 2014;42(1):1-7.

  51. Senturk S, Ulusoy S, Bosgelmez-Tinaz G, Yagci A. Quorum sensing and virulence of Pseudomonas aeruginosa during urinary tract infections. J Infect Develop Countries. 2012;6(06):501-7.

  52. Kumar R, Chhibber S, Gupta V, Harjai K. Screening and profiling of quorum sensing signal molecules in Pseudomonas aeruginosa isolates from catheterized urinary tract infection patients. Indian J Med Res. 2011; 134(2):208.

  53. Chowdhury N, Bagchi A. Molecular insight into the activity of LasR protein from Pseudomonas aeruginosa in the regulation of virulence gene expression by this organism. Gene. 2016;580(1):80-7.

  54. Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. Antimicrobial resistance. JAMA. 2016;316(11): 1193-204.

  55. Betts JW, Wareham DW. In vitro activity of curcumin in combination with epigallocatechin gallate (EGCG) versus multidrug-resistant Acinetobacter baumannii. BMC Microbiol. 2014;14(1):172.

  56. Bahari S, Zeighami H, Mirshahabi H, Roudashti S, Haghi F. Inhibition of Pseudomonas aeruginosa quorum sensing by subinhibitory concentrations of curcumin with gentamicin and azithromycin. J Global Antimicrob Resist. 2017;10:21-8.

  57. Packiavathy IASV, Priya S, Pandian SK, Ravi AV. Inhibition of biofilm development of uropathogens by curcumin-an anti-quorum sensing agent from Curcuma longa. Food Chem. 2014;148:453-60.

  58. Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM.Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Natur Prod. 2011; 74(4):664-9.

  59. Sasidharan NK, Sreekala SR, Jacob J, Nambisan B. In vitro synergistic effect of curcumin in combination with third generation cephalosporins against bacteria associated with infectious diarrhea. BioMed Res Int. 2014; 2014:8.

  60. Kali A, Devaraj Bhuvaneshwar P, Charles M, Seetha KS. Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates. J Basic Clin Pharm. 2016;7(3):93.

によって引用された
  1. Shukla Arpit, Parmar Paritosh, Rao Priyashi, Goswami Dweipayan, Saraf Meenu, Twin Peaks: Presenting the Antagonistic Molecular Interplay of Curcumin with LasR and LuxR Quorum Sensing Pathways, Current Microbiology, 77, 8, 2020. Crossref

  2. Parham Shokoh, Kharazi Anousheh Zargar, Bakhsheshi-Rad Hamid Reza, Nur Hadi, Ismail Ahmad Fauzi, Sharif Safian, RamaKrishna Seeram, Berto Filippo, Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials, Antioxidants, 9, 12, 2020. Crossref

  3. Xie Ying, Yao Yuan, Preparation and characterization of a solid dispersion containing curcumin and octenylsuccinate hydroxypropyl phytoglycogen for improved curcumin solubility, European Journal of Pharmaceutical Sciences, 153, 2020. Crossref

  4. Shukla Arpit, Parmar Paritosh, Patel Baldev, Goswami Dweipayan, Saraf Meenu, Breaking bad: Better call gingerol for improving antibiotic susceptibility of Pseudomonas aeruginosa by inhibiting multiple quorum sensing pathways, Microbiological Research, 252, 2021. Crossref

  5. Shukla Arpit, Shukla Gaurav, Parmar Paritosh, Patel Baldev, Goswami Dweipayan, Saraf Meenu, Exemplifying the next generation of antibiotic susceptibility intensifiers of phytochemicals by LasR-mediated quorum sensing inhibition, Scientific Reports, 11, 1, 2021. Crossref

  6. Cañon-Ibarra Andrés F., Sanchez-Castañeda M. Paola, Arbelaez Lina M., Sanchez Leidy T., Pinzon Magda I., Villa Cristian C., Natural Antimicrobials, in Natural Additives in Foods, 2023. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain